Reaction
Facial Asymmetry reporting signals
As of the last recalculation, Facial Asymmetry appears in 939 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is BOTULINUM TOXIN TYPE A (PRR 126.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Botulinum Toxin Type A | 66 | 126.7 | 127.3 |
| Onabotulinumtoxina | 243 | 93.8 | 94.1 |
| Temozolomide | 28 | 30.3 | 30.4 |
| Octreotide Acetate | 30 | 22.4 | 22.4 |
| Aprepitant | 12 | 14.6 | 14.6 |
| Paliperidone Palmitate | 7 | 4.9 | 4.9 |